{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T22:47:41Z","timestamp":1776293261221,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015803","name":"BC Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015803","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.clcc.2021.11.006","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T23:12:00Z","timestamp":1638313920000},"page":"107-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of Tumor Location on Patient Outcomes in Small Bowel Cancers"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6590-3409","authenticated-orcid":false,"given":"Irene S.","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6300-7013","authenticated-orcid":false,"given":"Zamzam","family":"Al-Hashami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0306-6756","authenticated-orcid":false,"given":"Parv","family":"Chapani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2361-4681","authenticated-orcid":false,"given":"Caroline","family":"Speers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3834-6835","authenticated-orcid":false,"given":"Janine M.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard J.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Renouf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3306-3617","authenticated-orcid":false,"given":"Sharlene","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2806-9184","authenticated-orcid":false,"given":"Heather C.","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8189-2132","authenticated-orcid":false,"given":"Jonathan M.","family":"Loree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2021.11.006_bib0001","series-title":"Surveillance, Epidemiology, and End Results Program","year":"2020"},{"key":"10.1016\/j.clcc.2021.11.006_bib0002","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/SLA.0b013e31818e4641","article-title":"Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years","volume":"249","author":"Bilimoria","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.clcc.2021.11.006_bib0003","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bpg.2016.02.007","article-title":"Physiology of intestinal absorption and secretion","volume":"30","author":"Kiela","year":"2016","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.clcc.2021.11.006_bib0004","series-title":"Surveillance, Epidemiology, and End Results Program","year":"2020"},{"key":"10.1016\/j.clcc.2021.11.006_bib0005","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nrclinonc.2013.132","article-title":"Small bowel adenocarcinomas\u2013existing evidence and evolving paradigms","volume":"10","author":"Raghav","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.clcc.2021.11.006_bib0006","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/jamaoncol.2017.1051","article-title":"Genomic profiling of small-bowel adenocarcinoma","volume":"3","author":"Schrock","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clcc.2021.11.006_bib0007","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/sj.bjc.6605449","article-title":"Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine","volume":"102","author":"Overman","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clcc.2021.11.006_bib0008","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/hmg\/10.7.735","article-title":"Deficient DNA mismatch repair: A common etiologic factor for colon cancer","volume":"10","author":"Peltom\u00e4ki","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.clcc.2021.11.006_bib0009","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/cncr.20404","article-title":"Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients","volume":"101","author":"Dabaja","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2021.11.006_bib0010","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.amjsurg.2009.05.037","article-title":"A single-institution experience with 491 cases of small bowel adenocarcinoma","volume":"199","author":"Halfdanarson","year":"2010","journal-title":"Am J Surg"},{"key":"10.1016\/j.clcc.2021.11.006_bib0011","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jss.2020.03.017","article-title":"Small bowel adenocarcinomas: impact of location on survival","volume":"252","author":"Lee","year":"2020","journal-title":"J Surg Res"},{"key":"10.1016\/j.clcc.2021.11.006_bib0012","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.3747\/co.26.5719","article-title":"Current and emerging biomarkers in metastatic colorectal cancer","volume":"26","author":"Lee","year":"2019","journal-title":"Curr Oncol"},{"key":"10.1016\/j.clcc.2021.11.006_bib0013","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The american joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clcc.2021.11.006_bib0014","unstructured":"BC Cancer Genetics and Genomics Laboratory. Oncopanel (Solid Tumor NGS Panel). Available at http:\/\/cancergeneticslab.ca\/genes\/oncopanel. Accessed August 12, 2020."},{"key":"10.1016\/j.clcc.2021.11.006_bib0015","unstructured":"RARECARE. Surveillance of rare cancers in Europe. Available at http:\/\/www.rarecare.eu\/rarecancers\/rarecancers.asp. Accessed August 7, 2020."},{"key":"10.1016\/j.clcc.2021.11.006_bib0016","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1245\/s10434-011-2173-6","article-title":"A population-based comparison of adenocarcinoma of the large and small intestine: Insights into a rare disease","volume":"19","author":"Overman","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clcc.2021.11.006_bib0017","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1002\/(SICI)1097-0142(19991215)86:12<2693::AID-CNCR14>3.0.CO;2-U","article-title":"The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985-1995","volume":"86","author":"Howe","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2021.11.006_bib0018","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1002\/cncr.25324","article-title":"Prognostic value of lymph node evaluation in small bowel adenocarcinoma","volume":"116","author":"Overman","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2021.11.006_bib0019","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/S0959-8049(96)00244-4","article-title":"Survival in small intestinal adenocarcinoma","volume":"32A","author":"Zar","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clcc.2021.11.006_bib0020","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/ijc.32860","article-title":"Small bowel adenocarcinoma: Results from a nationwide prospective ARCAD-NADEGE cohort study of 347 patients","volume":"147","author":"Aparicio","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clcc.2021.11.006_bib0021","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jamaoncol.2016.3797","article-title":"Prognostic and predictive relevance of primary tumor location in patients with RAS wild-type metastatic colorectal cancer: Retrospective analyses of the CRYSTAL and FIRE-3 trials","volume":"3","author":"Tejpar","year":"2017","journal-title":"JAMA Oncol"},{"issue":"suppl 15","key":"10.1016\/j.clcc.2021.11.006_bib0022","article-title":"Impact of primary (1\u00b0) tumor location on overall survival (OS) and progression-free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB\/SWOG 80405 (Alliance)","volume":"34","author":"Venook","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2021.11.006_bib0023","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1158\/1055-9965.EPI-10-1281","article-title":"Crohn's disease and small bowel adenocarcinoma: a population-based case\u2013control study","volume":"20","author":"Shaukat","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clcc.2021.11.006_bib0024","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1080\/0284186X.2016.1182211","article-title":"Trends in incidence, treatment and survival of small bowel adenocarcinomas between 1999 and 2013: a population-based study in The Netherlands","volume":"55","author":"Legu\u00e9","year":"2016","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clcc.2021.11.006_bib0025","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.ejca.2014.04.007","article-title":"ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma","volume":"50","author":"Laforest","year":"2014","journal-title":"Eur J Cancer"},{"issue":"suppl 15","key":"10.1016\/j.clcc.2021.11.006_bib0026","article-title":"Her2 expression in small bowel adenocarcinoma","volume":"36","author":"Adediran","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2021.11.006_bib0027","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1002\/ijc.33392","article-title":"Panel gene profiling of small bowel adenocarcinoma: Results from the NADEGE prospective cohort","volume":"148","author":"Aparicio","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clcc.2021.11.006_bib0028","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/cncr.29840","article-title":"Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: a propensity score-matched analysis","volume":"122","author":"Ecker","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2021.11.006_bib0029","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.34.15_suppl.TPS4154","article-title":"GLOBAL BALLAD: An international rare cancers initiative trial to evaluate the potential benefit of adjuvant chemotherapy for small bowel adenocarcinoma (IRCI 002)","volume":"34","author":"Evans","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2021.11.006_bib0030","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1002\/cncr.23822","article-title":"Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma","volume":"113","author":"Overman","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2021.11.006_bib0031","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/annonc\/mdq038","article-title":"Chemotherapy of advanced small-bowel adenocarcinoma: a multicenter AGEO study","volume":"21","author":"Zaanan","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2021.11.006_bib0032","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1002\/cncr.30766","article-title":"North Central Cancer Treatment Group N0543 (Alliance): A phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinoma","volume":"123","author":"McWilliams","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2021.11.006_bib0033","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/CAD.0b013e328350dd0d","article-title":"A phase II study of modified FOLFOX as first-line chemotherapy in advanced small bowel adenocarcinoma","volume":"23","author":"Xiang","year":"2012","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.clcc.2021.11.006_bib0034","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1200\/JCO.2008.19.7145","article-title":"Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater","volume":"27","author":"Overman","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2021.11.006_bib0035","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1634\/theoncologist.10-2-132","article-title":"Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma","volume":"10","author":"Gibson","year":"2005","journal-title":"Oncologist"},{"key":"10.1016\/j.clcc.2021.11.006_bib0036","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1158\/1078-0432.CCR-20-2892","article-title":"Characterization and clinical outcomes of DNA mismatch repair-deficient small bowel adenocarcinoma","volume":"27","author":"Latham","year":"2021","journal-title":"Clin Cancer Res"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002821001298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002821001298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:07:48Z","timestamp":1761520068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002821001298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1533002821001298"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2021.11.006","relation":{},"ISSN":["1533-0028"],"issn-type":[{"value":"1533-0028","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Tumor Location on Patient Outcomes in Small Bowel Cancers","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2021.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}